PPARα activation improves NASH by increasing FFA ß-oxidation (Stienstra et al., 2007) and lowering inflammation via negative cross-talk with NF-κB (Delerive et al., 1999). Here, NFKB1 is linked to metabolic dysfunction-associated steatohepatitis.